Pulmonary delivery of cisplatin-hyaluronan conjugates via endotracheal instillation for the treatment of lung cancer.
about
Nanotechnology-based inhalation treatments for lung cancer: state of the artSynthesis and characterization of a multi-arm poly(acrylic acid) star polymer for application in sustained delivery of cisplatin and a nitric oxide prodrug.Routes of administration and dose optimization of soluble antigen arrays in mice with experimental autoimmune encephalomyelitis.Fabrication of poly(γ-glutamic acid)-based biopolymer as the targeted drug delivery system with enhanced cytotoxicity to APN/CD13 over-expressed cells.Cellular uptake and internalization of hyaluronan-based doxorubicin and cisplatin conjugatesMulti-arm polymeric nanocarrier as a nitric oxide delivery platform for chemotherapy of head and neck squamous cell carcinoma.Exploring targeted pulmonary delivery for treatment of lung cancer.Hyaluronan-Lysine Cisplatin Drug Carrier for Treatment of Localized Cancers: Pharmacokinetics, Tolerability, and Efficacy in Rodents and Canines.Effects of intratumoral administration of a hyaluronan-cisplatin nanoconjugate to five dogs with soft tissue sarcomasImpact of molecular weight on lymphatic drainage of a biopolymer-based imaging agentPolymer-drug conjugates: recent progress on administration routes.Role of polymer-drug conjugates in organ-specific delivery systems.Development and Validation of an Inductively Coupled Plasma Mass Spectrometry (ICP-MS) Method for Quantitative Analysis of Platinum in Plasma, Urine, and Tissues.Enhancement of Aerosol Cisplatin Chemotherapy with Gene Therapy Expressing ABC10 protein in Respiratory System.Antitumor activity of intratracheal inhalation of temozolomide (TMZ) loaded into gold nanoparticles and/or liposomes against urethane-induced lung cancer in BALB/c mice.Highly sensitive and selective anticancer effect by conjugated HA-cisplatin in non-small cell lung cancer overexpressed with CD44.Synthesis and characterization of cisplatin-loaded, EGFR-targeted biopolymer and in vitro evaluation for targeted delivery.Heparan sulfate proteoglycan-mediated entry pathway for charged tri-platinum compounds: differential cellular accumulation mechanisms for platinum.Phase I-II clinical trial of hyaluronan-cisplatin nanoconjugate in dogs with naturally occurring malignant tumors.Intratracheal Administration of Hyaluronan-Cisplatin Conjugate Nanoparticles Significantly Attenuates Lung Cancer Growth in Mice.Microparticles of rifampicin: comparison of pulmonary route with oral route for drug uptake by alveolar macrophages, phagocytosis activity and toxicity study in albino rats.Histological Characteristics of the Tracheobronchial Tree of the Least Shrew (Cryptotis Parva).Formation of platinum (II) as a six member ring for sustained polymeric delivery.Polysaccharides for the Delivery of Antitumor Drugs.Tumour-microenvironment interactions: role of tumour stroma and proteins produced by cancer-associated fibroblasts in chemotherapy response.Hydration forces as a tool for the optimization of core–shell nanoparticle vectors for cancer gene therapy
P2860
Q26774177-4D773453-A57C-4666-A43A-23E9C67C71DFQ31019887-B5855805-AB3F-4376-8EDE-545477EAA724Q35032669-2227392E-7D22-4542-8ED1-ECD38546328EQ35554484-B55FDA5F-47B4-4193-AF3E-6C5FCB903AB4Q36204729-2BE925E2-C526-4DF2-8B8B-8CCA46C3C344Q36609101-AB3054A2-CDBF-4B68-A968-1AC01E9E5439Q36942012-C80A539A-C0E6-43A7-913E-4F8FFCA981E7Q36948510-1F38BFA7-FA87-453D-9338-A5A66AA295D2Q37186800-3B1057F1-DA84-45B8-901D-DC45520FB9D1Q37327825-BD9E1C3E-E917-40F4-B54E-8BD27D97A18FQ38206549-6B398FEE-13AF-41BB-AC86-5F7C71A6A4B8Q38365556-3BEF211D-A076-4901-A024-941E2426D9F1Q38436491-99B6F6FE-78CB-4F89-B997-41C548CC2DF4Q38689201-7A214878-2442-49CA-A5B5-3EA6350075FBQ38940380-9701EE50-56D0-4F3F-A43B-4FCE4F2B4472Q38949468-C4431DF2-CDF6-4743-A7BD-19CA638ADBA0Q39334984-DF7F353D-2FBE-47D0-8F76-0C502FA8B8D0Q39365949-9AC28949-27CC-4FFA-B0C0-8362316FF1C6Q39436032-E288E586-4A55-4614-8C9D-A5BD5A6945EEQ41656021-F3A5FCA6-6B91-45C2-8255-A850877184D0Q42241235-4E7BE37D-FC9E-4E3A-B390-4B11E69185AAQ42509200-8BB41925-C15E-4C7B-9D0E-BF08C5DA205DQ48034557-30FD778C-6336-4B63-A13A-CD707927DDEDQ50347968-66BDA3DA-6CF8-4737-8C6C-D4CC4DCE90BDQ52841791-98A3F8DD-2D6E-498D-B557-480CDA81D6B0Q57610433-54E8B013-E564-4F99-A5B2-E01B169B40AA
P2860
Pulmonary delivery of cisplatin-hyaluronan conjugates via endotracheal instillation for the treatment of lung cancer.
description
2010 nî lūn-bûn
@nan
2010 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Pulmonary delivery of cisplati ...... the treatment of lung cancer.
@ast
Pulmonary delivery of cisplati ...... the treatment of lung cancer.
@en
type
label
Pulmonary delivery of cisplati ...... the treatment of lung cancer.
@ast
Pulmonary delivery of cisplati ...... the treatment of lung cancer.
@en
prefLabel
Pulmonary delivery of cisplati ...... the treatment of lung cancer.
@ast
Pulmonary delivery of cisplati ...... the treatment of lung cancer.
@en
P2093
P2860
P1476
Pulmonary delivery of cisplati ...... r the treatment of lung cancer
@en
P2093
Cory J Berkland
Jason M Christian
Kristin L Aillon
Neal M Davies
Shuang Cai
P2860
P304
P356
10.1016/J.IJPHARM.2010.03.058
P407
P577
2010-04-02T00:00:00Z